Moreover, cleavage products of APP accumulate at mitochondria-associated endoplasmic reticulum membranes (MAMs), where it impairs mitochondrial bioenergetics, disrupts cellular lipid homeostasis, and leads to alterations in membrane lipid components common in AD pathogenesis [21, 22]. This evidence concerns the gene APP and Alzheimer disease.